Science, Space and Technology News 2024
Semaglutide treatment significantly enhances health outcomes for patients with heart failure with preserved ejection fraction , showing reduced dependency on loop diuretics, and improvements in symptoms and physical limitations.
A total of 1,145 patients were included from 129 sites across 18 countries in Asia, Europe, North America, and South America. The average age was ~70 years and ~50% were women. At baseline, 220 patients were not receiving diuretics, 223 were receiving non-loop diuretics only, and 702 were receiving loop diuretics.
Regarding the first primary endpoint of change in heart failure-related symptoms and physical limitations from baseline to 52 weeks, semaglutide improved KCCQ-CSS in all diuretic subgroups, but the magnitude of improvement was greater in patients receiving loop diuretics compared to those not on loop diuretics, with an adjusted mean difference vs. placebo of +9.3 vs. +4.7 points , respectively; p interaction=0.042.
For the second primary endpoint of percentage change in body weight from baseline to 52 weeks, semaglutide had a consistent beneficial effect across diuretic use categories. The adjusted mean difference vs. placebo ranged from -8.8% to -6.9% from no diuretics to the highest loop diuretic dose category; p interaction=0.39. Semaglutide had consistent beneficial effects on all secondary efficacy endpoints across diuretic subgroups .
Between baseline and 52 weeks, loop diuretic dose decreased by 17% in the semaglutide group vs. a 2.4% increase in the placebo group . Semaglutide was more likely to result in loop diuretic dose reduction and less likely to result in loop diuretic dose increase ; p<0.001 for both. There were fewer serious adverse events with semaglutide vs. placebo across diuretic subgroups.Study author Dr.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Semaglutide, gastric bypass delay weight loss plateau, study findsChloe Nordquist is a national journalist for the E.W. Scripps Company. She has a passion for telling community stories and giving a voice to the voiceless. Chloe has had the opportunity to report across the world, as far as Milan and Berlin. Previously she worked at news stations in California’s Central Valley and Southwest Florida.
Read more »
Beyond Weight Loss and Diabetes, Ozempic Could Help Certain Heart ConditionsEveryone has been talking about Wegovy and Ozempic for weight loss. But Semaglutide could be used for heart conditions and even alcohol use disorder.
Read more »
Cognitive factors may influence attrition, weight loss, and weight maintenance.Specific cognitive factors are associated with attrition, weight loss, and maintenance, but are not usually addressed by the treatment of obesity
Read more »
Moving beyond weight stigma in the armed forces.The dark reality behind military fitness standards includes a silent epidemic of eating disorders among service members.
Read more »
‘Lunar Lander Beyond’ Review: Lands Well, But Doesn’t Go BeyondI'm a British writer who loves indies, reviewing games regardless of platform or budget, with a soft spot for anything retro. I've been on juries for BAFTA and Gamescom.
Read more »
Family Pressure To Lose Weight In Adolescence Linked to Internalized Weight StigmaAnuradha Varanasi is a freelance science writer. She writes on the intersection of health/medicine, racial disparities, and climate change. She earned an MA in Science Journalism from Columbia University in New York City.
Read more »